GL
IRWD icon

Gerber LLC’s Ironwood Pharmaceuticals IRWD Stock Holding History

Gerber LLC’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,600
Closed -$105K – 95
2024
Q4 		$105K Sell
23,600
-11,000
-32% -$44.6K 0.08% 89
2024
Q3 		$143K Hold
34,600
– – 0.1% 89
2024
Q2 		$226K Buy
34,600
+7,000
+25% +$49.5K 0.18% 83
2024
Q1 		$240K Hold
27,600
– – 0.2% 80
2023
Q4 		$316K Buy
+27,600
New +$273K 0.28% 64

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Gerber LLC's IRWD Position: Q1 2025 in Review

Gerber LLC sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 23,600 shares — an estimated $105K sold.

Gerber LLC first reported a position in IRWD in Q4 2023 and held it in 5 quarters. The position peaked at $316K in Q4 2023. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Gerber LLC reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Gerber LLC sold 23,600 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $105K.
  • Gerber LLC first reported a position in Ironwood Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Gerber LLC's Ironwood Pharmaceuticals position peaked at $316K in Q4 2023.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Gerber LLC's 13F filing for Q1 2025, filed 23 Apr 2025.